BASKING RIDGE, N.J., Jan. 21, 2022 /PRNewswire-PRWeb/ — For the second consecutive year,Valiance Partners, a global leader in critical data migration services within the pharmaceutical, biotechnology, medical device and consumer products regulated industries has received the highest partner acknowledgement to certify their expertise in Veeva Development Cloud: Vault Clinical Operations Suite, Quality Suite and Vault RIM Suite for migrations.
“Veeva’s continued recognition of Valiance Partners, an NNIT company, as a leader in life sciences data migration services, validates our methodology and underscores our success in meeting the evolving needs of our clients, our ability to reduce risk, cost, streamline efforts, and support the migration of legacy data,” said Tom Witmer, Vice President – Business Development; Valiance Partners. “We are delighted to continue building on our long-standing partnership and provide exceptional experiences to our joint-customers.”
To receive certifications and be selected as a Veeva Premiere Services Partner, Valiance Partners completed numerous projects and supplied customer references to demonstrate successful engagements for the Veeva Vault RIM Suite, Veeva Vault Quality Suite, and Veeva Vault Clinical Operations Suite, verifying Valiance’s expertise in Veeva technologies, as well as their adherence to Veeva best practices.
As a result of Valiance Partners’ specialized regulatory knowledge, robust business processes and precision in client engagements, Veeva and leading life science companies trust Valiance Partners with their critical Vault migrations and archiving services.
About Valiance Partners
The first official Veeva Migration Certified Partner, Valiance Partners is a leading vendor for high-risk data and content migrations when compliance and business risk demand “getting it right.” For more information, visit http://www.valiancepartners.com.
CONTACT INFORMATION
Tom Witmer
Partner/Vice President – Business Development
Valiance Partners
twitmer@valiancepartners.com
973.632.3994
Media Contact
Tom Witmer, Valiance Partners, +1 (973) 632-3994, twitmer@ValiancePartners.com
SOURCE Valiance Partners
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…